Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes

被引：0
|
作者：
Emily J. Gallagher
Zara Zelenko
Aviva Tobin-Hess
Ulrich Werner
Norbert Tennagels
Derek LeRoith
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine
[2] Sanofi-Aventis Deutschland GmbH,Diabetes Research & Translational Medicine, Insulin Biology
来源：
Diabetologia | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：758 / 759
页数：1
相关论文
共 50 条
  • [1] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Emily J. Gallagher
    Zara Zelenko
    Aviva Tobin-Hess
    Ulrich Werner
    Norbert Tennagels
    Derek LeRoith
    Diabetologia, 2016, 59 : 2018 - 2025
  • [2] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Gallagher, Emily J.
    Zelenko, Zara
    Tobin-Hess, Aviva
    Werner, Ulrich
    Tennagels, Norbert
    LeRoith, Derek
    DIABETOLOGIA, 2016, 59 (09) : 2018 - 2025
  • [3] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes (vol 59, pg 2018, 2016)
    Gallagher, Emily J.
    Zelenko, Zara
    Tobin-Hess, Aviva
    Werner, Ulrich
    Tennagels, Norbert
    LeRoith, Derek
    DIABETOLOGIA, 2017, 60 (04) : 758 - 759
  • [4] Insulin Glargine Does Not Increase Breast Cancer Growth in an Animal Model
    Gallagher, Emily Jane
    Tobin-Hess, Aviva
    Blank, Jeffrey
    Buffin, Nicholas
    Polin, Ashley
    Tennagels, Norbert
    Werner, Ulrich
    Leroith, Derek
    DIABETES, 2013, 62 : A470 - A470
  • [5] Insulin glargine does not increase breast cancer growth in an animal model
    Gallagher, E. J.
    Tobin-Hess, A.
    Blank, J.
    Buffin, N.
    Polin, A.
    Tennagels, N.
    Werner, U.
    LeRoith, D.
    DIABETOLOGIA, 2013, 56 : S320 - S320
  • [6] Insulin Glargine and (A21Gly, DiD-Arg) Insulin Do Not Promote Breast Cancer Growth in a Mouse Model
    Gallagher, Emily J.
    Tennagels, Norbert
    Werner, Ulrich
    Leroith, Derek
    DIABETES, 2015, 64 : A493 - A493
  • [7] Insulin glargine and (A21Gly,DiD-Arg) insulin do not promote breast cancer growth in a mouse model
    Gallagher, E.
    Tennagels, N.
    Werner, U.
    LeRoith, D.
    DIABETOLOGIA, 2015, 58 : S262 - S262
  • [8] Phthalates Promote the Development of Type 2 Diabetes in a Hyperlipidemic Mouse Model
    Zhou, Wei
    Shi, Weibin
    DIABETES, 2014, 63 : A391 - A391
  • [9] Type 2 diabetes, insulin treatment and prognosis of breast cancer
    Mu, Lan
    Zhu, Nannan
    Zhang, Jiao
    Xing, Fang
    Li, Daiqing
    Wang, Xin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (01)
  • [10] SEVERITY OF BREAST CANCER ASSOCIATED WITH TYPE 2 DIABETES AND NOT WITH INSULIN TREATMENT
    Overbeek, J. A.
    van Herk-Sukel, M. P.
    Vissers, P. A.
    van der Heijden, A. A.
    Bronsveld, H. K.
    Herings, R. M.
    Schmidt, M. K.
    Nijpels, G.
    VALUE IN HEALTH, 2018, 21 : S16 - S16
12345